BioStable Science & Engineering is a cardiovascular device company focused on developing and commercializing proprietary valve repair technologies that provide an alternative to valve replacement for patients with aortic valve disease. The company’s HAART Aortic Repair Technologies are designed to simplify and standardize aortic valve repair, enabling surgeons to offer the recognized clinical benefits of valve repair to patients undergoing surgical correction of aortic insufficiency or aortic root aneurysm.
To learn more about BioStable Science and Engineering, visit www.biostable-s-e.com.
Orlando Health continues to receive some of the most prestigious national accolades in healthcare, including Best Hospital awards from U.S. News & World Report and Fortune Magazine, Top Hospital awards from the patient safety advocates at The Leapfrog Group and Beacon Awards for excellence at the patient bedside from the American Association of Critical-Care Nurses.
The organization also owns Orlando Health Strategic Innovations, an innovation platform that includes a corporate venture fund that invests in promising early-stage healthcare companies from around the world.
David currently serves as a vice chair of the Christus Health Board in Dallas, TX, chairing the Finance and Strategy Committee, and serving on the Executive and Governance Committees. He is vice chair of the Teaching Hospital Council of Florida and chair of the Florida Chamber of Commerce’s Central Florida Regional Board. In addition, David is on the boards of BioStable Science & Engineering, Inc. in Austin, TX, the Safety Net Hospital Alliance of Florida (also serving on the Executive Committee), the Florida Chamber of Commerce and the Florida Hospital Association.